 Marseille, France, Aug. 30, 2021 GLOBE NEWSWIRE -- Innate Pharma SA Euronext Paris: IPH ISIN: FR0010331421; Nasdaq: IPHA Innate or the Company today announced that members of its senior management team are scheduled to participate in the following upcoming virtual investor conferences: 